Eiko LifeSciences Statistics
Total Valuation
BOM:540204 has a market cap or net worth of INR 724.74 million. The enterprise value is 660.26 million.
| Market Cap | 724.74M |
| Enterprise Value | 660.26M |
Important Dates
The next estimated earnings date is Thursday, January 29, 2026.
| Earnings Date | Jan 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:540204 has 14.54 million shares outstanding. The number of shares has increased by 15.43% in one year.
| Current Share Class | 14.54M |
| Shares Outstanding | 14.54M |
| Shares Change (YoY) | +15.43% |
| Shares Change (QoQ) | +0.49% |
| Owned by Insiders (%) | 35.55% |
| Owned by Institutions (%) | 4.07% |
| Float | 5.31M |
Valuation Ratios
The trailing PE ratio is 19.55.
| PE Ratio | 19.55 |
| Forward PE | n/a |
| PS Ratio | 1.76 |
| PB Ratio | 1.22 |
| P/TBV Ratio | 1.23 |
| P/FCF Ratio | 112.75 |
| P/OCF Ratio | 6.63 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.13, with an EV/FCF ratio of 102.72.
| EV / Earnings | 19.18 |
| EV / Sales | 1.60 |
| EV / EBITDA | 12.13 |
| EV / EBIT | 14.68 |
| EV / FCF | 102.72 |
Financial Position
The company has a current ratio of 8.40, with a Debt / Equity ratio of 0.02.
| Current Ratio | 8.40 |
| Quick Ratio | 6.69 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.19 |
| Debt / FCF | 1.57 |
| Interest Coverage | 18.22 |
Financial Efficiency
Return on equity (ROE) is 7.35% and return on invested capital (ROIC) is 4.80%.
| Return on Equity (ROE) | 7.35% |
| Return on Assets (ROA) | 4.50% |
| Return on Invested Capital (ROIC) | 4.80% |
| Return on Capital Employed (ROCE) | 7.01% |
| Revenue Per Employee | 58.77M |
| Profits Per Employee | 4.92M |
| Employee Count | 7 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 13.62 |
Taxes
In the past 12 months, BOM:540204 has paid 13.32 million in taxes.
| Income Tax | 13.32M |
| Effective Tax Rate | 24.67% |
Stock Price Statistics
The stock price has decreased by -6.03% in the last 52 weeks. The beta is -0.01, so BOM:540204's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | -6.03% |
| 50-Day Moving Average | 52.79 |
| 200-Day Moving Average | 52.75 |
| Relative Strength Index (RSI) | 39.93 |
| Average Volume (20 Days) | 8,199 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:540204 had revenue of INR 411.42 million and earned 34.43 million in profits. Earnings per share was 2.55.
| Revenue | 411.42M |
| Gross Profit | 84.37M |
| Operating Income | 43.05M |
| Pretax Income | 54.00M |
| Net Income | 34.43M |
| EBITDA | 52.50M |
| EBIT | 43.05M |
| Earnings Per Share (EPS) | 2.55 |
Balance Sheet
The company has 80.87 million in cash and 10.09 million in debt, with a net cash position of 70.78 million or 4.87 per share.
| Cash & Cash Equivalents | 80.87M |
| Total Debt | 10.09M |
| Net Cash | 70.78M |
| Net Cash Per Share | 4.87 |
| Equity (Book Value) | 594.08M |
| Book Value Per Share | 42.62 |
| Working Capital | 250.10M |
Cash Flow
In the last 12 months, operating cash flow was 109.34 million and capital expenditures -102.91 million, giving a free cash flow of 6.43 million.
| Operating Cash Flow | 109.34M |
| Capital Expenditures | -102.91M |
| Free Cash Flow | 6.43M |
| FCF Per Share | 0.44 |
Margins
Gross margin is 20.51%, with operating and profit margins of 10.46% and 8.37%.
| Gross Margin | 20.51% |
| Operating Margin | 10.46% |
| Pretax Margin | 13.12% |
| Profit Margin | 8.37% |
| EBITDA Margin | 12.76% |
| EBIT Margin | 10.46% |
| FCF Margin | 1.56% |
Dividends & Yields
BOM:540204 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.43% |
| Shareholder Yield | -15.43% |
| Earnings Yield | 4.75% |
| FCF Yield | 0.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |